Sign in
4

Changes in Ownership

IRONWOOD PHARMACEUTICALS INC Filed Acc 0000950170-24-063481

CMO,SVP,Head-Res&Drug sold 16,128 shares at $6.45 ($104,026)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Shetzline Michael CMO,SVP,Head-Res&Drug 2024-05-20 Sale −16,128 $6.45 $104,026 413,719 D
Open-market sales · 16,128 sh · avg $6.45 · $104,026
Loading xslF345X05/ownership.xml…